Projects
DIGIT
The world is undergoing a digital transition that is changing our societies and economies at an unprecedented speed, accelerated by the COVID-19 pandemic. Through the DIGIT project, we will gather insights into the asthma and COPD patient digital journey.
Atopic Eczema Consensus Europe
In 2021, EFA is running a project to fill the awareness gap and develop a Consensus among the burden of Atopic Eczema/Dermatitis for Patients.
3TR
3TR is an IMI funded project studying the molecular pathways and mechanisms linked to response and non-response to therapy in different immune-mediated, allergic and inflammatory diseases, including asthma and COPD.
CURE
More than 30 million Europeans live with asthma. CURE is an Horizon 2020 project that is testing if a phage therapy (virus) could control the immune dysregulation of asthma, and to eventually be able to cure it.
Campaigns
Endorse the Breathe Vision for 2030
The Breathe Vision for 2030 outlines shared aims by respiratory partners to increase attention towards respiratory health, while also supporting the general awareness and understanding of lung disease in society.
Show your support to the Breathe Vision for 2030!
World Atopic Eczema Day
Every year on September 14th, EFA and the global community mark World Atopic Eczema Day, an opportunity to rise awareness about atopic eczema and improve understanding about the challenges it poses for people living with it.
#ShowLeadership
#ShowLeadership is a pan-European campaign encouraging policymakers, stakeholders and individuals to take action to improve the situation of allergy, asthma and COPD patients in Europe. Only together, change is possible
Severely Asthma
Severely, ASTHMA! is a video series portraying six severe asthma patients and their families throughout Europe, each bringing a unique insight on diagnosis, care, social and family life, participating in research and living with air pollution.
Publications
Annual Report 2020
Our Annual Report looks back on our work throughout 2020. Despite a challenging year, the EFA community remained strong and resilient, and connected.
European Allergy and Asthma Youth Parliament: Policy Recommendations
The European Allergy and Asthma Youth Parliament launched its EU policy recommendations: "Growing up with Allergy and Asthma – How EU policymakers can support young allergy and asthma patients to live better lives"
Towards a Breathe Vision for 2030
The Breathe Vision paper outlines key changes that lung patients want to see in their lives by 2030, as a joint initiative by European level patient groups and healthcare professionals. The paper aims to increase awareness of respiratory health, improve lung health care and research, and tackle COVID-19 and its long-term impacts in Europe.
FoodDETECTives Report
The FoodDETECTives report puts a focus on the implementation of the EU Regulation on Food Information to Consumers and its provisions on food allergen labelling, and provides a set of recommendations on how to overcome legislative gaps.
Atopic Eczema Report
Atopic eczema affects 3% of adults and 20% of children in the EU. This report encapsulates the results from the biggest-ever Quality of Life survey, and shakes the prevailing view on atopic eczema’s effects on patients.
